Literature DB >> 33485178

Effect of hypothyrodism's medication (T4) on implant osstointegration: A case series and literature search.

Mariam Al-Hindi1, Randa Al-Fotawi2, Abdulaziz Al-Tamimi3, Osama Khalil3, Naif Al-Osaimi3, Khalid Al-Ghamdi3, Khloud Heji4.   

Abstract

INTRODUCTION: Hypothyroidism reduces the recruitment, maturation, and activity of bone cells, decreasing bone resorption and formation. Several investigations have reported that T4 replacement therapy is associated with a significant decrease in bone mineral density in various skeletal parts, while others have failed to corroborate these results. The present study describes both a literature review and our own experience with dental implants in patients with hypothyroidism undergoing T4 replacement therapy. CASE
PRESENTATION: The study included two parts: a literature review and case series. The literature review included 12 articles documenting the success rate of osseointegrated dental implants in patients with hypothyroidism. The clinical cases were chosen from King Saud University Dental College, Riyadh. The patients' identity was only available to the main researcher. The inclusion criteria for the clinical cases were: T4-treated hypothyroidism, age 20-60 years, and use of dental implants with a follow-up period of 6-12 months after loading. The exclusion criteria were: any other medical condition alongside hypothyroidism, syndromic hypothyroidism, pregnancy, current smoking, bruxism, and hypothyroidism caused by surgical excision combined with radiotherapy. The following parameters were assessed: insertion torque (IT), crestal bone height (CBH), mesial bone width (MBW), and distal bone width (DBW) at different time points, probing depth, and signs of infection. DISCUSSION: Seventeen dental implants placed in patients with T4-treated hypothyroidism showed median IT success (42.4 N⋅cm; range: 35-45 N⋅cm). The median crestal bone loss was measured at 6-12 months after loading was 0.6 mm (range: 0.5-0.7. mm). Conversely, the median bone loss differences in MBW and DBW at 6-12 months after loading were 0.3 mm and 0.2 mm, respectively.
CONCLUSION: After a 1-year follow-up, patients with T4-treated hypothyroidism who had received dental implants fulfilled the criteria for successful implants.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Dental implants; Hypothyroid disease; Medically compromised patient; Osseointegration; T4

Year:  2021        PMID: 33485178      PMCID: PMC7820912          DOI: 10.1016/j.ijscr.2021.01.040

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  1 in total

Review 1.  Patients with Thyroid Disorder, a Contraindication for Dental Implants? A Systematic Review.

Authors:  Aina Torrejon-Moya; Keila Izquierdo-Gómez; Mario Pérez-Sayáns; Enric Jané-Salas; Antonio Marí Roig; José López-López
Journal:  J Clin Med       Date:  2022-04-25       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.